IMMUNOSUPPRESSION
Clinical trials for IMMUNOSUPPRESSION explained in plain language.
Never miss a new study
Get alerted when new IMMUNOSUPPRESSION trials appear
Sign up with your email to follow new studies for IMMUNOSUPPRESSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids with Crohn's: testing better drug combinations
Disease control Recruiting nowThis study is testing whether using two types of medications together works better than using just one to control Crohn's disease in children and teenagers. Researchers will compare how well the treatments reduce symptoms and gut inflammation over about a year. The goal is to fin…
Matched conditions: IMMUNOSUPPRESSION
Phase: PHASE4 • Sponsor: Children's Hospital of Fudan University • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Liver scan could cut lifelong drug burden for transplant patients
Disease control Recruiting nowThis study aims to see if a special ultrasound scan (FibroScan) can help doctors safely reduce the amount of anti-rejection drugs people need to take after a liver transplant. Participants who are at least 2 years post-transplant and stable will have their drug doses carefully lo…
Matched conditions: IMMUNOSUPPRESSION
Phase: NA • Sponsor: University of Alberta • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Gene-Guided dosing aims to improve kidney transplant success
Disease control Recruiting nowThis study is testing whether checking a patient's genes before a kidney transplant can help doctors prescribe the correct starting dose of a crucial anti-rejection drug called tacrolimus. It will compare this genetic-guided approach to the current standard of care to see if it g…
Matched conditions: IMMUNOSUPPRESSION
Phase: PHASE4 • Sponsor: Instituto de Investigación Hospital Universitario La Paz • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC
-
One pill a day? study tests simpler drug routine for liver transplant patients
Disease control Recruiting nowThis study is testing if taking all anti-rejection drugs once a day is as safe and effective as taking them twice a day for people who have received a liver transplant. The goal is to make the lifelong medication routine easier to follow, which could help patients stick to their …
Matched conditions: IMMUNOSUPPRESSION
Phase: PHASE4 • Sponsor: University Hospital, Limoges • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Medical first: robotic bladder transplant trial begins
Disease control Recruiting nowThis is the first-ever study to test transplanting a whole bladder from a deceased donor into a patient with end-stage bladder disease. The goal is to see if this robotic surgery is a feasible and better-tolerated alternative to current major surgeries that use a piece of bowel. …
Matched conditions: IMMUNOSUPPRESSION
Phase: NA • Sponsor: University of Southern California • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC
-
Scientists probe why trauma survivors get stuck in a cycle of sickness
Knowledge-focused Recruiting nowThis study aims to understand why some people who survive severe injuries later develop serious infections and long-term health problems. Researchers will collect blood and bone marrow samples from 255 adults with major trauma injuries and compare them to samples from people havi…
Matched conditions: IMMUNOSUPPRESSION
Sponsor: University of Florida • Aim: Knowledge-focused
Last updated Apr 04, 2026 01:35 UTC
-
Scientists probe link between immune defects and gum disease
Knowledge-focused Recruiting nowThis study aims to understand how genetic immune system problems affect oral health, particularly gum disease. Researchers will compare people with immune disorders, those with severe gum disease, and healthy volunteers by collecting samples like saliva, plaque, and blood. The go…
Matched conditions: IMMUNOSUPPRESSION
Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC